Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma

Russell Maxwell, Andrew S. Luksik, Tomas Garzon-Muvdi, Wuyang Yang, Judy Huang, Chetan Bettegowda, George I. Jallo, Stephanie A. Terezakis, Mari L. Groves

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Pediatric high-grade brainstem gliomas are aggressive tumors with dismal prognoses. Large-scale studies are needed to further characterize these tumors and determine factors influencing cancer-specific mortality and survival at varying time points. Methods: We used the SEER (Surveillance Epidemiology and End Results) database to conduct a population-based study of pediatric patients with histologically confirmed anaplastic astrocytoma or glioblastoma tumors located within the brainstem. Multivariate analyses incorporating patient demographics, tumor characteristics, and treatments were used to determine predictors of cancer-specific mortality and survival at 6 months, 9 months, 1 year, and 2 years. Results: We included 154 patients from the SEER database: 72 patients with anaplastic astrocytoma (47%) and 82 (53%) with glioblastoma. Median survival for the entire cohort was 10.0 months. Glioblastoma histology, developmental stage, and large tumor size were significantly associated with cancer-specific mortality. Six-month, 9-month, 1-year, and 2-year survival was 75%, 57%, 42%, and 20%, respectively. Glioblastoma histology was associated with worsened survival at 6 months (odds ratio [OR], 0.19; P = 0.0081), 9 months (OR, 0.18; P < 0.001), 1 year (OR, 0.19; P < 0.001), and 2 years (OR, 0.14; P = 0.0055). Radiation therapy was associated with improved survival at 6 (OR, 8.53; P = 0.0012) and 9 months (OR, 3.58; P = 0.035) but not at 1 or 2 years. Radiation therapy was associated with improved survival in glioblastoma (9.0 vs. 3.0 months; P < 0.001). Conclusions: This population-based study showed that glioblastoma histology is associated with a poor prognosis in pediatric patients with high-grade brainstem gliomas. Regardless of histology, radiation therapy improved survival at 6 and 9 months but not long-term.

Original languageEnglish (US)
Pages (from-to)e1006-e1015
JournalWorld Neurosurgery
Volume119
DOIs
StatePublished - Nov 2018
Externally publishedYes

Fingerprint

Glioma
Brain Stem
Glioblastoma
Pediatrics
Survival
Mortality
Odds Ratio
Population
Neoplasms
Histology
Radiotherapy
Astrocytoma
Epidemiology
Databases
Multivariate Analysis
Demography

Keywords

  • Anaplastic astrocytoma
  • Brainstem glioma
  • Diffuse intrinsic pontine glioma
  • Glioblastoma
  • Radiation therapy
  • SEER

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma. / Maxwell, Russell; Luksik, Andrew S.; Garzon-Muvdi, Tomas; Yang, Wuyang; Huang, Judy; Bettegowda, Chetan; Jallo, George I.; Terezakis, Stephanie A.; Groves, Mari L.

In: World Neurosurgery, Vol. 119, 11.2018, p. e1006-e1015.

Research output: Contribution to journalArticle

Maxwell, Russell ; Luksik, Andrew S. ; Garzon-Muvdi, Tomas ; Yang, Wuyang ; Huang, Judy ; Bettegowda, Chetan ; Jallo, George I. ; Terezakis, Stephanie A. ; Groves, Mari L. / Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma. In: World Neurosurgery. 2018 ; Vol. 119. pp. e1006-e1015.
@article{956847ba76f44475a452e3c1c3d09a31,
title = "Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma",
abstract = "Background: Pediatric high-grade brainstem gliomas are aggressive tumors with dismal prognoses. Large-scale studies are needed to further characterize these tumors and determine factors influencing cancer-specific mortality and survival at varying time points. Methods: We used the SEER (Surveillance Epidemiology and End Results) database to conduct a population-based study of pediatric patients with histologically confirmed anaplastic astrocytoma or glioblastoma tumors located within the brainstem. Multivariate analyses incorporating patient demographics, tumor characteristics, and treatments were used to determine predictors of cancer-specific mortality and survival at 6 months, 9 months, 1 year, and 2 years. Results: We included 154 patients from the SEER database: 72 patients with anaplastic astrocytoma (47{\%}) and 82 (53{\%}) with glioblastoma. Median survival for the entire cohort was 10.0 months. Glioblastoma histology, developmental stage, and large tumor size were significantly associated with cancer-specific mortality. Six-month, 9-month, 1-year, and 2-year survival was 75{\%}, 57{\%}, 42{\%}, and 20{\%}, respectively. Glioblastoma histology was associated with worsened survival at 6 months (odds ratio [OR], 0.19; P = 0.0081), 9 months (OR, 0.18; P < 0.001), 1 year (OR, 0.19; P < 0.001), and 2 years (OR, 0.14; P = 0.0055). Radiation therapy was associated with improved survival at 6 (OR, 8.53; P = 0.0012) and 9 months (OR, 3.58; P = 0.035) but not at 1 or 2 years. Radiation therapy was associated with improved survival in glioblastoma (9.0 vs. 3.0 months; P < 0.001). Conclusions: This population-based study showed that glioblastoma histology is associated with a poor prognosis in pediatric patients with high-grade brainstem gliomas. Regardless of histology, radiation therapy improved survival at 6 and 9 months but not long-term.",
keywords = "Anaplastic astrocytoma, Brainstem glioma, Diffuse intrinsic pontine glioma, Glioblastoma, Radiation therapy, SEER",
author = "Russell Maxwell and Luksik, {Andrew S.} and Tomas Garzon-Muvdi and Wuyang Yang and Judy Huang and Chetan Bettegowda and Jallo, {George I.} and Terezakis, {Stephanie A.} and Groves, {Mari L.}",
year = "2018",
month = "11",
doi = "10.1016/j.wneu.2018.08.044",
language = "English (US)",
volume = "119",
pages = "e1006--e1015",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma

AU - Maxwell, Russell

AU - Luksik, Andrew S.

AU - Garzon-Muvdi, Tomas

AU - Yang, Wuyang

AU - Huang, Judy

AU - Bettegowda, Chetan

AU - Jallo, George I.

AU - Terezakis, Stephanie A.

AU - Groves, Mari L.

PY - 2018/11

Y1 - 2018/11

N2 - Background: Pediatric high-grade brainstem gliomas are aggressive tumors with dismal prognoses. Large-scale studies are needed to further characterize these tumors and determine factors influencing cancer-specific mortality and survival at varying time points. Methods: We used the SEER (Surveillance Epidemiology and End Results) database to conduct a population-based study of pediatric patients with histologically confirmed anaplastic astrocytoma or glioblastoma tumors located within the brainstem. Multivariate analyses incorporating patient demographics, tumor characteristics, and treatments were used to determine predictors of cancer-specific mortality and survival at 6 months, 9 months, 1 year, and 2 years. Results: We included 154 patients from the SEER database: 72 patients with anaplastic astrocytoma (47%) and 82 (53%) with glioblastoma. Median survival for the entire cohort was 10.0 months. Glioblastoma histology, developmental stage, and large tumor size were significantly associated with cancer-specific mortality. Six-month, 9-month, 1-year, and 2-year survival was 75%, 57%, 42%, and 20%, respectively. Glioblastoma histology was associated with worsened survival at 6 months (odds ratio [OR], 0.19; P = 0.0081), 9 months (OR, 0.18; P < 0.001), 1 year (OR, 0.19; P < 0.001), and 2 years (OR, 0.14; P = 0.0055). Radiation therapy was associated with improved survival at 6 (OR, 8.53; P = 0.0012) and 9 months (OR, 3.58; P = 0.035) but not at 1 or 2 years. Radiation therapy was associated with improved survival in glioblastoma (9.0 vs. 3.0 months; P < 0.001). Conclusions: This population-based study showed that glioblastoma histology is associated with a poor prognosis in pediatric patients with high-grade brainstem gliomas. Regardless of histology, radiation therapy improved survival at 6 and 9 months but not long-term.

AB - Background: Pediatric high-grade brainstem gliomas are aggressive tumors with dismal prognoses. Large-scale studies are needed to further characterize these tumors and determine factors influencing cancer-specific mortality and survival at varying time points. Methods: We used the SEER (Surveillance Epidemiology and End Results) database to conduct a population-based study of pediatric patients with histologically confirmed anaplastic astrocytoma or glioblastoma tumors located within the brainstem. Multivariate analyses incorporating patient demographics, tumor characteristics, and treatments were used to determine predictors of cancer-specific mortality and survival at 6 months, 9 months, 1 year, and 2 years. Results: We included 154 patients from the SEER database: 72 patients with anaplastic astrocytoma (47%) and 82 (53%) with glioblastoma. Median survival for the entire cohort was 10.0 months. Glioblastoma histology, developmental stage, and large tumor size were significantly associated with cancer-specific mortality. Six-month, 9-month, 1-year, and 2-year survival was 75%, 57%, 42%, and 20%, respectively. Glioblastoma histology was associated with worsened survival at 6 months (odds ratio [OR], 0.19; P = 0.0081), 9 months (OR, 0.18; P < 0.001), 1 year (OR, 0.19; P < 0.001), and 2 years (OR, 0.14; P = 0.0055). Radiation therapy was associated with improved survival at 6 (OR, 8.53; P = 0.0012) and 9 months (OR, 3.58; P = 0.035) but not at 1 or 2 years. Radiation therapy was associated with improved survival in glioblastoma (9.0 vs. 3.0 months; P < 0.001). Conclusions: This population-based study showed that glioblastoma histology is associated with a poor prognosis in pediatric patients with high-grade brainstem gliomas. Regardless of histology, radiation therapy improved survival at 6 and 9 months but not long-term.

KW - Anaplastic astrocytoma

KW - Brainstem glioma

KW - Diffuse intrinsic pontine glioma

KW - Glioblastoma

KW - Radiation therapy

KW - SEER

UR - http://www.scopus.com/inward/record.url?scp=85052914010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052914010&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2018.08.044

DO - 10.1016/j.wneu.2018.08.044

M3 - Article

C2 - 30138731

AN - SCOPUS:85052914010

VL - 119

SP - e1006-e1015

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

ER -